José Morales
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Assistant Professor
Also affiliated: Universidad San Pablo CEU (2013); Universidad de Las Palmas de Gran Canaria (1991); Universidad Complutense de Madrid (1990–2020); Texas Tech University (1992–2006); Cedars-Sinai Medical Center (1969); United Nations (2018); Boston Children's Hospital (2014); Mayo Clinic (2022); Harvard University (2014); Johns Hopkins University (2015); University of California, Los Angeles (2021–2026); Pontificia Universidad Católica de Chile (2023–2024); Ronald Reagan UCLA Medical Center (2023); King Saud University (2009); Hospital Clínico San Carlos (2009); University of Oxford (2018); Research Institute Hospital 12 de Octubre (1995–2020); Ruhrlandklinik (1981); Los Angeles Medical Center (2026); King Khaled Eye Specialist Hospital (2007–2017); Hospital Universitario 12 De Octubre (1989–2020); Institute for Biomedicine (2019); Hospital Universitario Reina Sofía (1991); De Gruyter Brill (Germany) (2017); Instituto de Investigaciones Eléctricas (1991); Universidad Técnica de Ambato (2015); Hospital Universitario Virgen del Rocío (1996); Hospital Universitario de León (2005–2016); Hospital Universitario Ramón y Cajal (2002); Pharmacoeconomics and Health Outcomes Research Iberia (Spain) (2007); Complejo Asistencial Universitario de León (2013); Imperial College London (2010); University of Córdoba (1991); Wilfrid Laurier University (2018); Universidad de Navarra (1970); Universidad de León (2008–2016); University of Hong Kong (2018); Texas Tech University Health Sciences Center (1998–2006)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
José Morales is an Assistant Professor and Neurointerventional Surgeon at the University of Arkansas for Medical Sciences. His research interests span various areas, including the development of miniaturized transducers for localized cavitation, the study of aging-associated immune deficiencies, and the investigation of intracranial atherosclerotic disease. He has also explored robotic diagnostic cerebral angiography and microfabrication approaches for dental research and simulating dental aging.
Morales's academic background includes training in neurology, vascular neurology, and interventional neuroradiology from Northwestern University and the University of California Los Angeles. His earlier research at Harvard Medical School focused on the neuroanatomical correlates of critical period plasticity, and his Master of Science from Imperial College London involved investigating functional connectivity in memory and language networks associated with aging.
With an h-index of 41 and over 277 publications, Morales has a substantial record of scholarly output. He is also the founder of Vonova, Inc. His work contributes to fields such as neuroscience, medical imaging, and materials science, with a particular emphasis on neurovascular conditions and advanced medical technologies.
Metrics
- h-index: 40
- Publications: 262
- Citations: 4,603
Positions
-
Assistant Professor 2025–presentUniversity of Arkansas for Medical Sciences Neurology ORCID
-
Co-Founder 2019–presentVonova MedTech Startup ORCID
-
Neurointerventional Surgery Attending 2023–2025Pacific Neuroscience Institute Neurosurgery ORCID
-
Interventional Neuroradiology Clinical Instructor/Fellow 2021–2023University of California, Los Angeles Radiology ORCID
-
Vascular Neurology Fellow 2020–2021University of California Neurology ORCID
-
Resident 2017–2020McGaw Medical Center of Northwestern University Neurology ORCID
-
Transitional Year Intern 2016–2017Louis A Weiss Memorial Hospital Medicine ORCID
-
Research Assistant 2015The University of Chicago Section of Neurosurgery ORCID
-
Research Assistant Level II 2010–2011Boston Children's Hospital FM Kirbey Neurobiology Center ORCID
Selected Publications
-
Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations (2026)
Collaboration Network
Top Collaborators
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
- Middle meningeal artery as a pathway to innovative treatments: ARISE III consensus recommendations
Similar Researchers
Based on overlapping research topics